Shigematsu S, Yamada T, Aizawa T, Takasu N, Shimizu Z
Department of Gerontology, Endocrinology, and Metabolism, School of Medicine, Shinshu University, Matsumotoshi, Japan.
Angiology. 1992 Jan;43(1):40-6. doi: 10.1177/000331979204300105.
The physiology of atrial natriuretic peptide (ANP) secretion was studied in normotensive subjects and hypertensive patients both young and old. Basal plasma ANP concentration was least in young normotensives, intermediate in old normotensives and young hypertensives, and highest in old hypertensives. Nifedipine, a known stimulator of ANP secretion, acutely increased plasma ANP in young and old normotensive subjects but not in young hypertensive patients and half of the old hypertensive patients. Increase in serum ANP level in response to nifedipine did not augment its hypotensive effect. However, the increase of aldosterone in response to nifedipine-induced rise in plasma renin activity (PRA) seemed to be suppressed by elevated ANP.
在年轻和老年的血压正常受试者以及高血压患者中研究了心房利钠肽(ANP)分泌的生理学。基础血浆ANP浓度在年轻血压正常者中最低,在老年血压正常者和年轻高血压患者中居中,而在老年高血压患者中最高。硝苯地平是一种已知的ANP分泌刺激剂,它能使年轻和老年血压正常受试者的血浆ANP急性升高,但对年轻高血压患者和一半的老年高血压患者无效。硝苯地平引起的血清ANP水平升高并未增强其降压作用。然而,硝苯地平引起的血浆肾素活性(PRA)升高所导致的醛固酮增加似乎被升高的ANP所抑制。